Company / Cost of Revenue
MANNKIND CORP Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$26.8M
FY2025
5-year range
$16.0M / $26.8M
FY2021-FY2025
Trend
+53.8%
vs FY2024
Sector context
#58 of 83
Health Care
What the data says
At $27M, MANNKIND CORP's cost of revenue ranks #26 of 83 in the Health Care sector. Cost of Revenue has fluctuated over the past 10 years, ranging from $15M in FY2020 to $27M in FY2025.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of +12.2%.
Increased from $21M to $27M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +18.8%
- 5-Year CAGR
- +12.2%
- 10-Year CAGR
- -
Sector benchmark
#26 of 83 in Health CareTop 30% of 83This company $26.8M Sector average $2.0B
▼
-98.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.2%, indicating consistent growth.
- In FY2025, cost of revenue increased 53.8% year-over-year.
- Ranks #58 out of 83 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.8M | +53.8% |
| FY2024 | $17.4M | -16.5% |
| FY2023 | $20.9M | +30.4% |
| FY2022 | $16.0M | -4.9% |
| FY2021 | $16.8M | +11.6% |
| FY2020 | $15.1M | -24.9% |
| FY2019 | $20.1M | +3.5% |
| FY2018 | $19.4M | +12.6% |
| FY2017 | $17.2M | +0.6% |
| FY2016 | $17.1M | -73.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026